A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease

Itzhak Mendel; Anat Shoham; Oshrat Propheta-Meiran; Eti Ishai; Gideon Halperin; Erez Feige; Eyal Breitbart

doi:10.1016/j.jneuroim.2010.06.011

A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease

Itzhak Mendel, Anat Shoham, Oshrat Propheta-Meiran, Eti Ishai, Gideon Halperin, Erez Feige, Eyal Breitbart

VBL Therapeutics

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Oxidized phospholipids (Ox-PLs) are generated in abundance at sites of inflammation. Recent studies have indicated that Ox-PLs may also exhibit anti-inflammatory activities. In this study, we investigated the beneficial effect of VB-201, a pure synthetic Ox-PL analog that we synthesized, on the development of a central nervous system (CNS) autoimmune inflammatory disease, in vivo. Oral administration of VB-201 ameliorated the severity of experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) peptide MOG35-55, and restrained the encephalogenicity of MOG35-55-specific T-cells. Our data presents a novel prospect for the role of Ox-PL analogs in CNS inflammatory diseases.

Original language	English
Pages (from-to)	126-135
Number of pages	10
Journal	Journal of Neuroimmunology
Volume	226
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2010.06.011
State	Published - 14 Sep 2010
Externally published	Yes

Keywords

Experimental autoimmune encephalomyelitis
Oxidized phospholipids
T-cells

Access to Document

10.1016/j.jneuroim.2010.06.011

Cite this

@article{cb9585a7f9d245b7a3065a658c65f35e,

title = "A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease",

abstract = "Oxidized phospholipids (Ox-PLs) are generated in abundance at sites of inflammation. Recent studies have indicated that Ox-PLs may also exhibit anti-inflammatory activities. In this study, we investigated the beneficial effect of VB-201, a pure synthetic Ox-PL analog that we synthesized, on the development of a central nervous system (CNS) autoimmune inflammatory disease, in vivo. Oral administration of VB-201 ameliorated the severity of experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) peptide MOG35-55, and restrained the encephalogenicity of MOG35-55-specific T-cells. Our data presents a novel prospect for the role of Ox-PL analogs in CNS inflammatory diseases.",

keywords = "Experimental autoimmune encephalomyelitis, Oxidized phospholipids, T-cells",

author = "Itzhak Mendel and Anat Shoham and Oshrat Propheta-Meiran and Eti Ishai and Gideon Halperin and Erez Feige and Eyal Breitbart",

year = "2010",

month = sep,

day = "14",

doi = "10.1016/j.jneuroim.2010.06.011",

language = "אנגלית",

volume = "226",

pages = "126--135",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier B.V.",

number = "1-2",

}

TY - JOUR

T1 - A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease

AU - Mendel, Itzhak

AU - Shoham, Anat

AU - Propheta-Meiran, Oshrat

AU - Ishai, Eti

AU - Halperin, Gideon

AU - Feige, Erez

AU - Breitbart, Eyal

PY - 2010/9/14

Y1 - 2010/9/14

N2 - Oxidized phospholipids (Ox-PLs) are generated in abundance at sites of inflammation. Recent studies have indicated that Ox-PLs may also exhibit anti-inflammatory activities. In this study, we investigated the beneficial effect of VB-201, a pure synthetic Ox-PL analog that we synthesized, on the development of a central nervous system (CNS) autoimmune inflammatory disease, in vivo. Oral administration of VB-201 ameliorated the severity of experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) peptide MOG35-55, and restrained the encephalogenicity of MOG35-55-specific T-cells. Our data presents a novel prospect for the role of Ox-PL analogs in CNS inflammatory diseases.

AB - Oxidized phospholipids (Ox-PLs) are generated in abundance at sites of inflammation. Recent studies have indicated that Ox-PLs may also exhibit anti-inflammatory activities. In this study, we investigated the beneficial effect of VB-201, a pure synthetic Ox-PL analog that we synthesized, on the development of a central nervous system (CNS) autoimmune inflammatory disease, in vivo. Oral administration of VB-201 ameliorated the severity of experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) peptide MOG35-55, and restrained the encephalogenicity of MOG35-55-specific T-cells. Our data presents a novel prospect for the role of Ox-PL analogs in CNS inflammatory diseases.

KW - Experimental autoimmune encephalomyelitis

KW - Oxidized phospholipids

KW - T-cells

UR - http://www.scopus.com/inward/record.url?scp=77956340243&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2010.06.011

DO - 10.1016/j.jneuroim.2010.06.011

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 20663571

AN - SCOPUS:77956340243

SN - 0165-5728

VL - 226

SP - 126

EP - 135

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -

A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this